Measure of Engagement of Epilepsy Patients in Messaging Groups

Sponsor
Royal Free Hospital NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT03076645
Collaborator
(none)
202
5
1
10.3
40.4
3.9

Study Details

Study Description

Brief Summary

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Facilitator support and education
N/A

Detailed Description

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Study Design

Study Type:
Interventional
Actual Enrollment :
202 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Aug 10, 2017
Actual Study Completion Date :
Aug 10, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

The Experimental Group will be placed in a group using the matching algorithm. Facilitator support and education intervention

Behavioral: Facilitator support and education
Group engaged with facilitator support and education

Outcome Measures

Primary Outcome Measures

  1. Engagement [6 weeks]

    Average participant number of posts over time frame assessed by tracking number of participant entries

Secondary Outcome Measures

  1. Epilepsy self-management [Change in Baseline to 6 weeks]

    Patient activation measure based on self-reported questionnaire

  2. Epilepsy medication adherence [Change in Baseline to 6 weeks]

    Medication adherence based on self-reported questionnaire

  3. Epilepsy quality of life [Change in Baseline to 6 weeks]

    Quality of life in epilepsy metric based on self-reported questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application
Exclusion Criteria:
  • A diagnosis of learning disability/difficulty, significant mental health conditionsÍž those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lewisham & Greenwich NHS Trust Lewisham United Kingdom SE4 2LA
2 Barts and The London NHS Trust London United Kingdom E1 1BB
3 Royal Free Hospital London United Kingdom NW3 2QG
4 National Hospital for Neurology and Neurosurgery London United Kingdom WC1N 3BG
5 Kent Community Health NHS Trust Maidstone United Kingdom ME15 7AT

Sponsors and Collaborators

  • Royal Free Hospital NHS Foundation Trust

Investigators

  • Principal Investigator: Adina Nash, Royal Free London NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abbas Hasan, Honorary Researcher, Royal Free Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT03076645
Other Study ID Numbers:
  • 203594
First Posted:
Mar 10, 2017
Last Update Posted:
Oct 12, 2017
Last Verified:
Oct 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2017